1. Home
  2. ANVS vs TIL Comparison

ANVS vs TIL Comparison

Compare ANVS & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANVS
  • TIL
  • Stock Information
  • Founded
  • ANVS 2008
  • TIL 2018
  • Country
  • ANVS United States
  • TIL United States
  • Employees
  • ANVS N/A
  • TIL N/A
  • Industry
  • ANVS Biotechnology: Pharmaceutical Preparations
  • TIL Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANVS Health Care
  • TIL Health Care
  • Exchange
  • ANVS Nasdaq
  • TIL Nasdaq
  • Market Cap
  • ANVS 44.6M
  • TIL 230.1M
  • IPO Year
  • ANVS 2020
  • TIL 2021
  • Fundamental
  • Price
  • ANVS $2.86
  • TIL $24.49
  • Analyst Decision
  • ANVS Strong Buy
  • TIL Buy
  • Analyst Count
  • ANVS 4
  • TIL 5
  • Target Price
  • ANVS $18.00
  • TIL $119.00
  • AVG Volume (30 Days)
  • ANVS 433.6K
  • TIL 315.0K
  • Earning Date
  • ANVS 08-14-2025
  • TIL 08-12-2025
  • Dividend Yield
  • ANVS N/A
  • TIL N/A
  • EPS Growth
  • ANVS N/A
  • TIL N/A
  • EPS
  • ANVS N/A
  • TIL N/A
  • Revenue
  • ANVS N/A
  • TIL N/A
  • Revenue This Year
  • ANVS N/A
  • TIL N/A
  • Revenue Next Year
  • ANVS N/A
  • TIL N/A
  • P/E Ratio
  • ANVS N/A
  • TIL N/A
  • Revenue Growth
  • ANVS N/A
  • TIL N/A
  • 52 Week Low
  • ANVS $1.11
  • TIL $9.70
  • 52 Week High
  • ANVS $13.91
  • TIL $92.00
  • Technical
  • Relative Strength Index (RSI)
  • ANVS 57.81
  • TIL 47.69
  • Support Level
  • ANVS $2.24
  • TIL $21.80
  • Resistance Level
  • ANVS $2.97
  • TIL $26.91
  • Average True Range (ATR)
  • ANVS 0.26
  • TIL 3.35
  • MACD
  • ANVS 0.02
  • TIL -0.32
  • Stochastic Oscillator
  • ANVS 65.58
  • TIL 35.14

About ANVS Annovis Bio Inc.

Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.

About TIL Instil Bio Inc.

Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.

Share on Social Networks: